Atr-101 Free Base Uses, Dosage, Side Effects and more
Atr-101 Free Base is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
| Trade Name | Atr-101 Free Base |
| Generic | Nevanimibe |
| Nevanimibe Other Names | Atr-101 free base, Nevanimibe |
| Type | |
| Formula | C27H39N3O |
| Weight | Average: 421.629 Monoisotopic: 421.309312888 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
